Transcriptomics

Dataset Information

0

Rapamycin treatment ameliorates HLA-B27-mediated gut inflammation and alters the microbiome in experimental spondyloarthritis


ABSTRACT: Rapamycin treatment reduced stool and colon histological scores in B27-Tg rats compared to vehicle-treated B27-Tg controls. Transcriptome analysis revealed that rapamycin reduced expression of key pro-inflammatory cytokines like Il17a, Il17f, Tnf, Il1a, IL1b, and Il22 in B27-Tg colon tissue compared to vehicle-treated B27-Tg controls. Ex vivo treatment of bulk immune cells isolated from B27-Tg rat colon with rapamycin (25 and 50 nM) reduced expression of Il17a, Il17f, Ifng, and Il22 compared to vehicle-treated cells. Rapamycin treatment decreased the abundance of cecum microbiota associated with inflammation in B27-Tg rats. Rapamycin also altered the gut microbiome in WT rats, without associated changes in the tissue transcriptome. Our study demonstrates that rapamycin treatment substantially reduces HLA-B27-mediated gut inflammation in experimental SpA. Results from this pre-clinical model suggest further evaluation of rapamycin as a therapeutic strategy in HLA-B27 associated diseases is warranted.

ORGANISM(S): Rattus norvegicus

PROVIDER: GSE308302 | GEO | 2026/03/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-01-11 | GSE34966 | GEO
2012-01-11 | E-GEOD-34966 | biostudies-arrayexpress
2024-10-17 | PXD047119 | Pride
2017-02-13 | PXD005502 | Pride
2014-01-17 | E-MEXP-3808 | biostudies-arrayexpress
2015-12-21 | E-MTAB-4167 | biostudies-arrayexpress
2009-07-17 | GSE11022 | GEO
2021-06-25 | GSE178833 | GEO
2009-07-16 | E-GEOD-11022 | biostudies-arrayexpress
2012-06-01 | GSE37588 | GEO